138 related articles for article (PubMed ID: 27409833)
1. Hypoxia-mediated alterations and their role in the HER-2/neuregulated CREB status and localization.
Steven A; Leisz S; Sychra K; Hiebl B; Wickenhauser C; Mougiakakos D; Kiessling R; Denkert C; Seliger B
Oncotarget; 2016 Aug; 7(32):52061-52084. PubMed ID: 27409833
[TBL] [Abstract][Full Text] [Related]
2. HER-2/neu mediates oncogenic transformation via altered CREB expression and function.
Steven A; Leisz S; Massa C; Iezzi M; Lattanzio R; Lamolinara A; Bukur J; Müller A; Hiebl B; Holzhausen HJ; Seliger B
Mol Cancer Res; 2013 Nov; 11(11):1462-77. PubMed ID: 24025972
[TBL] [Abstract][Full Text] [Related]
3. Linking CREB function with altered metabolism in murine fibroblast-based model cell lines.
Steven A; Leisz S; Wickenhauser C; Schulz K; Mougiakakos D; Kiessling R; Denkert C; Seliger B
Oncotarget; 2017 Nov; 8(57):97439-97463. PubMed ID: 29228623
[TBL] [Abstract][Full Text] [Related]
4. Colorectal Carcinogenesis: Connecting K-RAS-Induced Transformation and CREB Activity In Vitro and In Vivo.
Steven A; Heiduk M; Recktenwald CV; Hiebl B; Wickenhauser C; Massa C; Seliger B
Mol Cancer Res; 2015 Aug; 13(8):1248-62. PubMed ID: 25934695
[TBL] [Abstract][Full Text] [Related]
5. HER-2/neu-mediated down-regulation of biglycan associated with altered growth properties.
Recktenwald CV; Leisz S; Steven A; Mimura K; Müller A; Wulfänger J; Kiessling R; Seliger B
J Biol Chem; 2012 Jul; 287(29):24320-9. PubMed ID: 22582394
[TBL] [Abstract][Full Text] [Related]
6. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
Menendez JA; Vellon L; Oza BP; Lupu R
J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
[TBL] [Abstract][Full Text] [Related]
7. Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma.
Astolfi A; Landuzzi L; Nicoletti G; De Giovanni C; Croci S; Palladini A; Ferrini S; Iezzi M; Musiani P; Cavallo F; Forni G; Nanni P; Lollini PL
Am J Pathol; 2005 Apr; 166(4):1205-16. PubMed ID: 15793299
[TBL] [Abstract][Full Text] [Related]
8. Critical roles of the cAMP-responsive element-binding protein-mediated pathway in disorganized epithelial phenotypes caused by mitochondrial dysfunction.
Shibanuma M; Ishikawa F; Kobayashi M; Katayama K; Miyoshi H; Wakamatsu M; Mori K; Nose K
Cancer Sci; 2012 Oct; 103(10):1803-10. PubMed ID: 22726539
[TBL] [Abstract][Full Text] [Related]
9. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
10. Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Landis MD; Seachrist DD; Abdul-Karim FW; Keri RA
Oncogene; 2006 Jun; 25(23):3325-34. PubMed ID: 16434967
[TBL] [Abstract][Full Text] [Related]
11. HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
Dragowska WH; Warburton C; Yapp DT; Minchinton AI; Hu Y; Waterhouse DN; Gelmon K; Skov K; Woo J; Masin D; Huxham LA; Kyle AH; Bally MB
Mol Cancer Res; 2004 Nov; 2(11):606-19. PubMed ID: 15561777
[TBL] [Abstract][Full Text] [Related]
12. RhoA inhibits the hypoxia-induced apoptosis and mitochondrial dysfunction in chondrocytes via positively regulating the CREB phosphorylation.
Zhang K; Jiang D
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28254846
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of fatty acid synthase (FAS): a novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation.
Menendez JA; Mehmi I; Verma VA; Teng PK; Lupu R
Mol Carcinog; 2004 Nov; 41(3):164-78. PubMed ID: 15390078
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
15. Neuron-derived orphan receptor 1 transduces survival signals in neuronal cells in response to hypoxia-induced apoptotic insults.
Chio CC; Wei L; Chen TG; Lin CM; Shieh JP; Yeh PS; Chen RM
J Neurosurg; 2016 Jun; 124(6):1654-64. PubMed ID: 26613168
[TBL] [Abstract][Full Text] [Related]
16. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
Bai T; Luoh SW
Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
[TBL] [Abstract][Full Text] [Related]
17. Stable knockdown of CREB, HIF-1 and HIF-2 by replication-competent retroviruses abrogates the responses to hypoxia in hepatocellular carcinoma.
Shneor D; Folberg R; Pe'er J; Honigman A; Frenkel S
Cancer Gene Ther; 2017 Feb; 24(2):64-74. PubMed ID: 27934882
[TBL] [Abstract][Full Text] [Related]
18. CREB Negatively Regulates IGF2R Gene Expression and Downstream Pathways to Inhibit Hypoxia-Induced H9c2 Cardiomyoblast Cell Death.
Chen WK; Kuo WW; Hsieh DJ; Chang HN; Pai PY; Lin KH; Pan LF; Ho TJ; Viswanadha VP; Huang CY
Int J Mol Sci; 2015 Nov; 16(11):27921-30. PubMed ID: 26610485
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
20. A pivotal role of cyclic AMP-responsive element binding protein in tumor progression.
Abramovitch R; Tavor E; Jacob-Hirsch J; Zeira E; Amariglio N; Pappo O; Rechavi G; Galun E; Honigman A
Cancer Res; 2004 Feb; 64(4):1338-46. PubMed ID: 14973073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
